Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-27 to 2025-04-17
Current total value of award: $27907.2
Description: 4567780334!XOLAIR 300 MG/2 ML SYRINGE 2ML